Tusamitamab ravtansine

Tusamitamab Ravtansine (SAR-408701), is an antibody-drug conjugate (ADC) composed of CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule 5) targeting antibody and a cytotoxic maytansinoid tubulin inhibitor DM4, via a cleavable linker. Tusamitamab ravtansine has an average drug-to-antibody ratio (DAR) of n = 3.8. It has an approximate molecular weight of 148 kDa.This product is for research use only.

Product Details
Species Reactivity	Human
Type	Antibody-drug conjugate
ADC antibody	Tusamitamab (Anti-CEACAM5)
ADC cytotoxin (drug)	DM4
Immunogen	Human CEACAM5
DAR (Drug to Antibody Ratio)	~3.8
Purity	99%
Molecular Weight	148kDa
Storage Condition	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Storage Buffer	1x PBS